Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

By S. Ott, Meike Musfeldt, D. Wenderoth, J. Hampe, O. Brant, U. Fölsch, Kenneth N. Timmis, Stefan Schreiber. Gut, 2004

1,267 citations recorded by the source corpus.

Subfields: Food Science, Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/1f77d29bf2b7e9b1d3ffeda5d6e2b8d04498fc9b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Food Science

In Genetics

In Molecular Biology

Citations in the corpus

Development of the Human Infant Intestinal Microbiota (2007, neutral): “bowel disease [10,11], and necrotizing enterocolitis [12,13].”
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters (2015, result): “This feature is in contrast to that observed in the gut microbiota of patients with inflammatory bowel disease (IBD), which is characterized by significantly lower species richness than that observed in healthy controls [19,20].”
Bifidobacteria and Their Role as Members of the Human Gut Microbiota (2016, background): “REVIEW published: 15 June 2016 doi: 10.3389/fmicb.2016.00925 Frontiers in Microbiology | www.frontiersin.org 1 June 2016 | Volume 7 | Article 925 Edited by: Marco Ventura, University of Parma, Italy Reviewed by: Susana Delgado, Instituto de Productos Lácteos de Asturias-Consejo Superior Investigacio”
The first 1000 cultured species of the human gastrointestinal microbiota (2014, background): “…for the health, Lactobacilli are rarely detected as markers of the gastrointestinal microbiota dysbiosis, but such reports exist and include a reduced abundance in patients suffering from inflammatory bowel disease (Keighley et al., 1978; Ott et al., 2004), type 1 diabetes (Murri et al., 2013).”
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome (2019, background): “Human Firmicutes, Bacteroides species, Eubacterium species, Lactobacillus species Proteobacteria Enterobacteriaceae, Decrease Increase [157]”
Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD (2011, result): “Our results are consistent with findings at another mucosal site, the gastrointestinal tract, where decreases in the diversity of the microbiota are associated with increased incidence of inflammatory bowel disease [30,31].”
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease (2011, background): “We also demonstrated a reduction in bacterial diversity within IBD patients compared to controls and this is in agreement with several previous studies [24-27,56,57].”